drugset / Trial / NCT02157376

Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients

NCT02157376

Phase 3 Completed 343 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindPrevention

Summary

The efficacy of esomeprazole will be compared versus cimetidine (a drug that previously demonstrated prevention of bleeding events) during treatment period in proportion of patients for the prevention of upper GI bleeding.

Timeline

Start
2014-07
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cimetidine Small molecule 50 mg Intravenous
Subject Esomeprazole Small molecule 40 mg Intravenous